baber/WOPTO huggingface dataset:
Patent AU-2012307145-A1 (AU)
Title: A solid oxide fuel cell system
Inventor: BOZZOLO MICHELE
IPC: H01M8/04
Filed: 2012-08-30
Abstract: A solid oxide fuel cell system (10) comprises a solid oxide fuel cell stack (12) and a gas turbine engine (14). The solid oxide fuel cell stack (12) comprises a plurality of solid oxide fuel cells (16). The gas turbine engine (14) comprises a compressor (24) and a turbine (26). The compressor (24) supplies oxidant to the cathodes(22) of the fuel cells (16) via an oxidant ejector (60) and the oxidant ejector (60) supplies a portion of the unused oxidant from the cathodes (22) of the fuel cells (16) back to the cathodes (22) of the fuel cells (16) with the oxidant from the compressor (24). The fuel cell system (10) further comprises an additional compressor (64), an additional turbine (66), a cooler (70) and a recuperator (72). The compressor(24) supplies oxidant via the cooler (70) to the additional compressor(64) and the additional compressor(64) supplies oxidant to the oxidant ejector (60) via the recuperator (72). The solid oxide fuel cell stack (12) supplies exhaust gases to the turbine (26)and the turbine (26) supplies the exhaust gases through the recuperator (72) to heat the oxidant flowing through the recuperator (72).
Patent AU-2012380376-A1 (AU)
Title: Complex compounds of germanium, methods for producing same, and drugs
Inventor: ISAEV ALEXANDR DMITRIEVICH
IPC: A61P31/22
Filed: 2012-11-01
Abstract: The invention relates to the development of drugs intended for the prophylaxis and/or treatment of viral diseases caused, in particular, by herpes viruses. What are proposed are complex compounds of germanium having the general structural formula: Ge
Patent WO-2014094046-A1 (WO)
Title: Slurry for Treatment of Oxyanion Contamination in Water
Inventor: WINKS ANDREW EATON
IPC: B01J20/12
Filed: 2013-12-18
Abstract: A slurry for treatment of oxyanion contamination in water including: an expandable bentonite having at least 0.50% sodium as disodium monoxide; said bentonite having or being treated to have a sodium content in excess of 3.00% sodium as disodium monoxide so as to provide a sodium activated bentonite; said sodium activated bentonite being treated with rare earth salts selected from lanthanum, cerium, yttrium and dysprosium to provide a plurality of active sequestration sites within or associated with the sodium bentonite.
Patent AU-2013200403-A1 (AU)
Title: Dual metal seal system
Inventor: DUONG KHANH ANH
IPC: E21B33/03
Filed: 2013-01-23
Abstract: A wellhead seal assembly has a primary seal and a secondary seal, each seal forming a metal-to-metal seal between inner and outer wellhead members. A primary metal seal ring has inner and outer walls separated by a slot. A secondary metal seal is located below the seal ring and has a bottom portion that contacts an upward facing shoulder of a hanger. A primary energizing exerts downward force on the primary seal, causing a secondary energizing ring, located below the primary energizing ring, to energize the secondary seal. Once the secondary seal is energized, thus stopping downward movement of the primary seal and secondary energizing ring, the primary energizing ring energizes the primary seal. II s174 Fig. 1 130
Patent AU-2013202646-A1 (AU)
Title: Wagering game having enhanced display of winning symbols
Inventor: AOKI DION K
IPC: A63F13/00
Filed: 2013-04-05
Abstract: Abstract An outcome of a wagering game is evaluated to determine if it is a winning outcome. In response to the outcome being a winning outcome, it is determined if the winning outcome includes two or more groups of winning symbols. In response to determining that the winning outcome includes two or more groups of winning symbols, each of the two or more groups of winning symbols is visually highlight in a sequential fashion. Further, it is determined if each of the two or more groups includes winning symbols on two or more lines. In response to determining that one of the two or more groups includes winning symbols on two or more lines, the winning symbols on each of the two or more lines is visually highlighted in a sequential fashion. 0:)C: C=l LO( (0o cu-J C'~4 G (0U C:0 (0 (0
Patent AU-2013216852-A1 (AU)
Title: Methods and compositions for modulating Factor VII expression
Inventor: SWAYZE ERIC E
IPC: C07H21/04
Filed: 2013-02-08
Abstract: Disclosed herein are antisense compounds and methods for decreasing Factor VII and treating, preventing, or slowing progression of thromboembolic complications, hyperproliferative disorders, or inflammatory conditions in an individual in need thereof.
Patent AU-2013218710-A1 (AU)
Title: Organic thin film solar cell
Inventor: HAYAKAWA AKINOBU
IPC: H01L31/072
Filed: 2013-02-07
Abstract: The purpose of the present invention is to provide an organic thin film solar cell achieving high photoelectric conversion efficiency and exhibiting excellent durability. The present invention is an organic thin film solar cell having a photoelectric conversion layer, wherein, in the photoelectric conversion layer, an organic semiconductor site is in contact with a site containing the sulfide of an element in group 15 of the periodic table, and the organic semiconductor constituting the organic semiconductor site is a polythiophene derivative, a phthalocyanine derivative, a naphthalocyanine derivative or a benzoporphyrin derivative.
Patent AU-2013235641-A1 (AU)
Title: Tissue graft anchoring
Inventor: HARNER CHRISTOPHER D
IPC: A61F2/08
Filed: 2013-03-12
Abstract: A fixation device includes a member (26), a woven material (90, 112) attached to the member, and suture (118) extending through the woven material and including free regions for securing the woven material to a tissue graft. A method of securing a tissue graft includes providing a fixation member having a woven material attached thereto and suture extending through the woven material; determining a desired distance between the fixation member and a tissue graft; and attaching the woven material to the tissue graft using the suture at a position to obtain the desired distance.
Patent AU-2013237715-A1 (AU)
Title: System software interfaces for space-optimized block devices
Inventor: VAGHANI SATYAM
IPC: G06F12/00
Filed: 2013-10-04
Abstract: Interfaces to storage devices that employ storage space optimization technologies, such as thin provisioning, are configured to enable the benefits gained from such technologies to be sustained. Such an interface may be provided in a hypervisor of a virtualized computer system to enable the hypervisor to discover features of a logical unit number (LUN), such as whether or not the LUN is thinly provisioned, and also in a virtual machine (VM) of the virtualized computer system to enable the VM to discover features of a virtual disk, such as whether or not the virtual disk is thinly provisioned. The discovery of these features enables the hypervisor or the VM to instruct the underlying storage device to carry out certain operations such as an operation to deallocate blocks previously allocated to a logical block device, so that the storage device can continue to benefit from storage space optimization technologies implemented therein.
Patent AU-2013266772-A1 (AU)
Title: Wellbore servicing fluids and methods of making and using same
Inventor: KULKARNI DHANASHREE GAJANAN
IPC: C09K8/36
Filed: 2013-05-01
Abstract: A method of servicing a wellbore comprising placing an invert emulsion drilling fluid having an oleaginous continuous phase, a non-oleaginous discontinuous phase, and a fluid loss additive into a wellbore wherein the fluid loss additive comprises a quaternary ammonium compound containing at least one ester linkage. A method of servicing a wellbore comprising introducing a clay-free invert emulsion drilling fluid comprising distearoylethyl dimonium chloride to the wellbore. A wellbore servicing fluid comprising an invert emulsion drilling fluid having an oleaginous continuous phase, a non-oleaginous discontinuous phase, and a fluid loss additive into a wellbore wherein the fluid loss additive comprises an esterquat characterized by Structure A:
Patent AU-2013272236-A1 (AU)
Title: Wideband low latency repeater and methods
Inventor: SAVAGE LEE M
IPC: H04B17/40
Filed: 2013-03-29
Abstract: A signal repeater (200) includes a signal processing part (202) and a signal repeating part (204). The signal processing part includes a converter (300) configured to receive an input signal and to convert the input signal into quadrature signals, and a processor (302, 304, 306) configured to process the quadrature signals to determine one or more characteristics of the input signal, and to compare the one or more characteristics of the input signal and a plurality of predetermined characteristics to generate a comparison result. The signal repeating part (204) is configured to selectively repeat the input signal as a repeated signal in accordance with the comparison result.
Patent AU-2013297717-A1 (AU)
Title: Check valve
Inventor: AKAIKE NAOKI
IPC: F16K15/06
Filed: 2013-07-22
Abstract: Provided is a compact, low-cost check valve that can suppress pressure loss and can securely prevent backflow of a fluid. The check valve is provided with the following: a tubular body that forms part of a flow path through which a fluid flows; a first housing with a first valve hole through which the fluid flows, with a valve seat section formed on the downstream side of the inner circumference surface of the first valve hole; a valve body with a flat section at the peak thereof and comprising a valve head section that expands in diameter in a tapered shape toward the downstream side and a support rod linked to the valve head section; a spring member that impels the valve body toward the valve seat section; and a second housing comprising a connecting section that has a second valve hole, and a cylindrical body that is open to the upstream side and that has a receiving surface on the downstream side for one end of the spring member and a sliding hole in the center section through which the support rod of the valve body slides; wherein the cylindrical body of the second housing decreases in diameter in a tapered shape toward the downstream side and has therein a cutaway section formed in the upper edge opposing one surface in the downstream side of the valve head section of the valve body.
Patent AU-2013302649-A1 (AU)
Title: Phase correcting canalphone system and method
Inventor: HARVEY JERRY
IPC: H04R7/00
Filed: 2013-08-14
Abstract: A canalphone system may include a high audio driver carried by a canalphone housing, and a low audio driver carried by the canalphone housing adjacent to the high audio driver. The system may also include an acoustical-timer to phase correct a high audio signal from the high audio driver directed to the outside of the canalphone housing with delivery of a low audio signal from the low audio driver directed to the outside of the canalphone housing.
Patent AU-2013314814-A1 (AU)
Title: Use of 3-n-butyl isoindoline ketone in preparation of drugs for preventing and treating cerebral infarction
Inventor: ZHAO CHUNSHUN
IPC: A61K31/4035
Filed: 2013-09-10
Abstract: Disclosed is the use of the compound 3-n-butyl isoindoline ketone shown as formula I in the preparation of drugs for preventing and treating cerebral infarction. Since the compound has a structure of solid crystal, it has more freedom in terms of preparation, provides more choices for clinical medication and decreases medication costs, compared with the oily liquid form of the similar drug butylphthalide.
Patent AU-2013344388-A1 (AU)
Title: Implantable drug delivery compositions and methods of treatment thereof
Inventor: SCHWARZ ALEXANDER
IPC: A61K31/428
Filed: 2013-11-19
Abstract: Reservoir-based drug delivery compositions comprise an API (e.g., raloxifene, pramipexole, or lidocaine), methods of delivering the API from an implantable composition in a therapeutically effective amount to a subject, methods of treatment, subcutaneous delivery systems, and kits regarding the same. The reservoir-based drug delivery compositions may be implanted in order to deliver a therapeutically effective amount of the API to the subject for long periods of time (e.g., at least one month, at least six months, at least one year, at least 18 months, at least two years, at least 30 months, etc.). The therapeutically effective amount of API may be delivered at a pseudo-zero order rate (e.g., zero order rate).
Patent AU-2013348091-A1 (AU)
Title: Synthesis of spirocyclic isoxazoline derivatives
Inventor: GREENWOOD SEAN D W
IPC: C07D491/10
Filed: 2013-11-20
Abstract: The invention recites an improved process for preparing spirocyclic isoxazoline derivatives of Formula (1) wherein "*", R
Patent AU-2013350342-A1 (AU)
Title: Management system and management method of mining machine
Inventor: TOJIMA MASANORI
IPC: G05D1/00
Filed: 2013-07-30
Abstract: Docket No. PKOA-14025-PCT A management system of a mining machine includes a landmark that is placed at a mine and detects a relative position with respect to a mining machine able to run at 5 the mine with a non-contact sensor placed on the mining machine, a storage device that registers a position of the landmark detected using the Global Positioning System, and a processing device that sets, upon the registration, a prohibited area where an entry of the mining machine is 10 prohibited such that the position of the landmark is included in the prohibited.
Patent AU-2014200497-A1 (AU)
Title: Novel Composition for Treating Metabolic Syndrome
Inventor: CHEN CHIEN-HUNG
IPC: C12N15/09
Filed: 2014-01-30
Abstract: The invention relates to a composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5'-monophosphate-activated Protein kinase (AMPK) activator; a second agent that possesses anti-inflammatory activity; and a third agent that possesses serotonin activity.
Patent AU-2014201845-A1 (AU)
Title: System for managing vehicle information displayed on a plurality of vehicles
Inventor: WILSON PAUL
IPC: G06F3/14
Filed: 2014-03-26
Abstract: H:\lld\Intcrnoven\NRPorlbl\DCC\TLD\6123759l.doc-26/03/2014 A system for managing vehicle information displayed on a plurality of vehicles, said 5 system including a central computer system and plurality of electronic display devices (EDD), each being associated with one of said vehicles and each being in electronic communication with the central computer system (CCS). The CCS includes one or more computer processors; computer readable data storage; and a CCS computer program stored on said data storage, the CCS program being executable by the processors to perform the 10 steps of selecting a vehicle from said plurality of vehicles; generating vehicle data representing information about said vehicle; and sending said vehicle data to an associated one of said EDDs. Each one of said EDDs includes one or more computer processors; computer readable data storage; an EDD computer program stored on said data storage; and a visual display unit, the EDD program being executable by the processors to perform 15 the steps of receiving vehicle data from the CCS representing information about an associated vehicle; and displaying said vehicle data representing information about the associated vehicle on the visual display unit. Figure 1 800
Patent AU-2014202021-A1 (AU)
Title: Polypeptide and immune modulation
Inventor: KELLY DENISE
IPC: A61K35/74
Filed: 2014-04-10
Abstract: Polypeptide and Immune Modulation The present invention relates to Roseburia flagellin, and/or a polynucleotide sequence encoding sald Rosebura flagellin, and/or a vector comprising said polynucleotide sequence, 5 and/or a host cell, including bacteria, comprising said vector, and/or a host cell, including bacteria, comprising said polynucleotide sequence, for use in modulating the inflammation of a tissue or an organ in a subject,
Patent AU-2014204347-A1 (AU)
Title: Contamination-free, flexible closure system for use on at least partially flexible containers
Inventor: KOCH MARTIN
IPC: B65D33/00
Filed: 2014-01-02
Abstract: The invention relates to a closure (10, 20) having two profiled strips (11, 12; 21, 22) for an at least partially flexible container (1, 2) for connecting a first container (1) to a second container (2) in an environmentally sealed manner and in a closed docking position, and for conducting a flow in a flow direction (D) through the closure (10, 20) from the first container (1) into the second container (2) in an environmentally sealed manner and in an open docking position. The second container (2) has an identical closure (10, 20) which faces the first container (1) and which, in the open docking position, is in engagement with the closure (10, 20) of the first container (1), and together with the closure (10, 20) of the first container (1) defines a flow channel (3) for the throughflow in the flow direction (D). A substantial advantage of the invention is that the closures (10, 20) can be docked to each other and opened jointly in a single step by a separate slider. A further substantial advantage of the invention is that due to the dual functional nature of all the closure elements no closure element (13, 14; 23, 24) is exposed in the channel-upward direction to the material to be transferred during the transfer of material. The invention further relates to a slider (30) for connecting and separating such closures (10, 20), comprising an insertion side (31), on which the closures (10, 20) can be inserted into the slider (30) in insertion directions (A, B), which form an acute angle, and an output side (32) opposite the insertion side (31), on which the closures (10, 20), which are connected to each other and are open, can be led out from the slider (30) in a common slide direction (C).
Patent AU-2014210301-A1 (AU)
Title: Tridentate connexon and use thereof
Inventor: AN DEQIANG
IPC: C07D207/452
Filed: 2014-01-17
Abstract: Disclosed are a tridentate connexon and use thereof. The tridentate connexon can be used to prepare an antibody-drug conjugate as represented by formula I, wherein L is an antibody, antibody segment or protein; T is a tridentate connexon part; A is a cleavable connexon combination or an un-cleavable connexon part; D is a drug part; and n is an integer in the range from 0 to 8. The structure of the tridentate connexon part is as represented by formula II, wherein W is a substituted aryl, heteroaryl, chain alkyl, cycloalkyl, heterocyclic alkyl, or any combination thereof.
Patent AU-2014214751-A1 (AU)
Title: Specific sites for modifying antibodies to make immunoconjugates
Inventor: GEIERSTANGER BERNHARD HUBERT
IPC: A61P35/00
Filed: 2014-02-07
Abstract: The present invention provides specific sites for modifying antibodies or antibody fragments by replacing at least one native amino acid in the constant region of a parental antibody or antibody fragment with cysteine, which can be used as a site of attachment for a payload or linker-payload combination.
Patent AU-2014227923-A1 (AU)
Title: Method of dosing and use of soft anticholinergic esters
Inventor: BODOR NICHOLAS S
IPC: A61Q15/00
Filed: 2014-03-14
Abstract: Use of a compound having the formula (I) in the preparation of a medicament composition comprising from about 1.0% to about 25% of said compound and a pharmaceutically acceptable vehicle, for topical administration to skin of an area of a mammalian subject suffering from hyperhidrosis, before bedtime, such that compared to untreated, baseline conditions, sweat production is reduced by at least about 25% for at least about six (6) hours.
Patent AU-2014228801-A1 (AU)
Title: Building board with acoustical foam
Inventor: ATHARI CHRISTOPHER K
IPC: E04C2/288
Filed: 2014-03-14
Abstract: Disclosed is a building board construction that provides enhanced acoustical properties. In one possible embodiment, the board is a gypsum board with opposing facing sheets and an intermediate set gypsum core. An opened celled polymeric sheet is formed within the gypsum core and gives the resulting board enhanced sound absorption. In an alternative embodiment, individual pieces of polymeric foam are used in stead of the polymeric sheet. Also disclosed are various manufacturing methods whereby boards with enhanced acoustical properties can be formed in an continuous process. The various components of the present disclosure, and the manner in which they interrelate, are described in greater detail hereinafter.
Patent AU-2014230442-A1 (AU)
Title: Powder container and image forming apparatus
Inventor: KIKUCHI KENJI
IPC: G03G15/08
Filed: 2014-03-14
Abstract: A powder container contains powder used for forming an image and is to be attached to an image forming apparatus. The image forming apparatus includes: a conveying nozzle to convey the powder; a powder receiving hole that is provided on the conveying nozzle and receives the powder from the powder container; an apparatus main-body gear to transmit a driving force to the powder container; and a container receiving section that is arranged around the conveying nozzle and receives the powder container. The powder container includes: an opening that is provided on one end of the powder container in a longitudinal direction; a nozzle receiver that is arranged in the opening and receives the conveying nozzle; a rotary conveyor that rotates to convey the powder to the powder receiving hole; and a container gear that is provided near the opening and drives the conveyor by meshing with the apparatus main-body gear. The container gear is arranged so as to mesh with the apparatus main-body gear at a position closer to the opening than the powder receiving hole in the longitudinal direction. The opening is to mate with the container receiving section.
Patent AU-2014231028-A1 (AU)
Title: Sunscreen formulations
Inventor: MARTINO GARY THEODORE
IPC: A61Q17/04
Filed: 2014-03-10
Abstract: Sunscreen formulations with improved thickening and waterproofing properties include a polymer prepared from monomers including: styrene, a (meth)acrylic acid-containing monomer and an ester of acrylic acid or methacrylic acid or an acrylamide monomer, and an acrylic acid homopolymer thickener.
Patent AU-2014240516-A1 (AU)
Title: Systems and methods for isotopic source external beam radiotherapy
Inventor: DEMPSEY JAMES F
IPC: A61N5/10
Filed: 2014-03-11
Abstract: The subject matter described herein provides methods for developing an IMRT treatment plan for a radiotherapy system. In one aspect, the method can include providing initial treatment parameters. These parameters can include a number of isotopic beams, a transmission angle for each beam, a prescribed dose for a target, and dose volume histogram constraints. The method can further include determining an initial fluence map including one or more beamlets. The initial fluence map can specify a fluence value for each beamlet. The method can further include determining a delivery sequence for the fluence values in the initial fluence map. The delivery sequence can include one or more apertures formed by the leaves of a collimator. These apertures can have a specified size constrained to substantially less than a maximum size associated with the collimator when the isotopic beam is near a critical structure. Related apparatus and systems are also described.
Patent AU-2014249148-A1 (AU)
Title: Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2014-03-11
Abstract: [00147] The invention provides genetically modified non-human animals that express a humanized MHC II protein (humanized MHC II and polypeptides), as well as embryos, cells, and tissues comprising the same. Also provided are constructs for making said genetically modified animals and methods of making the same. Methods of using the genetically modified animals to study various aspects of human immune system are provided.